Advertisement

Supportive Care in Cancer

, Volume 27, Issue 3, pp 721–727 | Cite as

Nutritional interventions in elderly gastrointestinal cancer patients: the evidence from randomized controlled trials

  • Federico BozzettiEmail author
Review Article
  • 202 Downloads

Abstract

Literature concerning nutritional interventions in elderly patients with gastrointestinal cancer, with special reference to randomized clinical trials, has been critically reviewed. This segment of oncologic population was found to be penalized by a high prevalence of malnutrition and sarcopenia which translated in an increased rate of toxicity from chemotherapy, poor compliance with oncologic treatments, and, finally, with a poor prognosis. Attempts to reverse this condition included a potentiation of nutrients intake which should sequentially proceed through the use of dietary counseling and administration of standard or ω-3 fatty acid–enriched oral supplements to finally come to enteral or parenteral nutrition. Randomized clinical trials investigating the effects of simple dietary advice and use of standard oral supplements were disappointing as regards long-term compliance and results. Nutritional and clinical benefits were reported with the use of ω-3 fatty acid–enriched oral supplements and especially with long-term supplemental parenteral nutrition. Despite the general recommendation of the scientific community that emphasizes the use of the enteral route, whenever possible, for delivering the nutritional support, it appears from the literature that more consistent benefits can be achieved, especially in the long-term nutritional support, when an insufficient oral nutrition is partnered with intravenous nutrition.

Keywords

Gastrointestinal cancer Elderly cancer patients Malnutrition of cancer patients Sarcopenia in cancer patients Supplemental parenteral nutrition Nutritional interventions in elderly cancer patients 

Notes

Compliance with ethical standards

Conflict of interest statement

The authors declare that they have no conflict of interest.

References

  1. 1.
    Yancik R (2005) Population aging and cancer: a cross-national concern. Cancer J 11(6):437–441CrossRefGoogle Scholar
  2. 2.
    Yancik R, Ries LA (1994) Cancer in older persons. Magnitude of the problem - how do we apply what we know? Cancer 74:1995–2003CrossRefGoogle Scholar
  3. 3.
    Ferlay JSI, Ervik M, Dikshit R et al (2013) GLOBOCAN 2012 v1.0, Cancer incidence and mortality worldwide: IARC CancerBase No. 11 [Internet]. International Agency for Research on Cancer, LyonGoogle Scholar
  4. 4.
    Bozzetti F (2003) Nutritional issues in the care of the elderly patient. Crit Rev Oncol Hematol 48(2):113–121CrossRefGoogle Scholar
  5. 5.
    Lacau S, Guily J, Bouvard É et al (2017) NutriCancer: a French observational multicentre cross-sectional study of malnutrition in elderly patients with cancer. J Geriatr Oncol 9:74–80CrossRefGoogle Scholar
  6. 6.
    Veterans Affairs Total Parenteral Nutrition Cooperative Study Group (1991) Perioperative total parenteral nutrition in surgical patients. N Engl J Med 325(8):525–532CrossRefGoogle Scholar
  7. 7.
    Guigoz Y, Vellas J, Garry P (1994) Mini nutritional assessment: a practical assessment tool for grading the nutritional state of elderly patients. Facts Res Gerontol 4(supp. 2):15–59Google Scholar
  8. 8.
    Barret M, Malka D, Aparicio T, Dalban C, Locher C, Sabate JM, Louafi S, Mansourbakht T, Bonnetain F, Attar A, Taieb J (2011) Nutritional status affects treatment tolerability and survival in metastatic colorectal cancer patients: results of an AGEO prospective multicenter study. Oncology 81(5–6):395–402CrossRefGoogle Scholar
  9. 9.
    Sánchez-Lara K, Ugalde-Morales E, Motola-Kuba D, Green D (2013) Gastrointestinal symptoms and weight loss in cancer patients receiving chemotherapy. Br J Nutr 109(5):894–897CrossRefGoogle Scholar
  10. 10.
    Barret M, Antoun S, Dalban C, Malka D, Mansourbakht T, Zaanan A, Latko E, Taieb J (2014) Sarcopenia is linked to treatment toxicity in patients with metastatic colorectal cancer. Nutr Cancer 66(4):583–589CrossRefGoogle Scholar
  11. 11.
    Vagnildhaug OM, Blum D, Wilcock A, European Palliative Care Cancer Symptom study group et al (2017) The applicability of a weight loss grading system in cancer cachexia: a longitudinal analysis. J Cachexia Sarcopenia Muscle 8(5):789–797CrossRefGoogle Scholar
  12. 12.
    Fonck M, Brunet R, Becouarn Y et al (2011) Evaluation of efficacy and safety of FOLFIRI for elderly patients with gastric cancer: a first-line phase II study. Clin Res Hepatol Gastroenterol 35(12):823–830CrossRefGoogle Scholar
  13. 13.
    Aaldriks AA, van der Geest LG, Giltay EJ et al (2013) Frailty and malnutrition predictive of mortality risk in older patients with advanced colorectal cancer receiving chemotherapy. J Geriatr Oncol 4(3):218–262CrossRefGoogle Scholar
  14. 14.
    Paillaud E, Liuu E, Laurent M et al (2014) ELCAPA study group. Geriatric syndromes increased the nutritional risk in elderly cancer patients independently from tumour site and metastatic status. Clin Nutr 33(2):330–335CrossRefGoogle Scholar
  15. 15.
    Bosaeus I, Daneryd P, Lundholm K (2002) Dietary intake, resting energy expenditure, weight loss and survival in cancer patients. J Nutr 132(11 Suppl):3465S–3466SCrossRefGoogle Scholar
  16. 16.
    Fearon KC, Voss AC, Hustead DS (2006) Cancer Cachexia study group. Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis. Am J Clin Nutr 83(6):1345–1350CrossRefGoogle Scholar
  17. 17.
    Cederholm T, Barazzoni R, Austin P et al (2017) ESPEN guidelines on definitions and terminology of clinical nutrition. Clin Nutr 36(1):49–64CrossRefGoogle Scholar
  18. 18.
    Aviles A, Yanez J, Garcia EL et al (1995) Malnutrition as an adverse prognostic factor in patients with diffuse large cell lymphoma. Arch Med Res 26:31–34Google Scholar
  19. 19.
    Di Fiore F, Lecleire S, Pop D et al (2007) Baseline nutritional status is predictive of response to treatment and survival in patients treated by definitive chemoradiotherapy for a locally advanced esophageal cancer. Am J Gastroenterol 102:2557–2563CrossRefGoogle Scholar
  20. 20.
    Mitry E, Douillard JY, Van Cutsem E et al (2004) Predictive factors of survival in patients with advanced colorectal cancer: an individual data analysis of 602 patients included in irinotecan phase III trials. Ann Oncol 15:1013–1017CrossRefGoogle Scholar
  21. 21.
    Ross PJ, Ashley S, Priest K et al (2004) Do patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancers? Br J Cancer 90:1905–1911CrossRefGoogle Scholar
  22. 22.
    Andreyev HJN, Norman AR, Oates J, Cunningham D (1998) Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies? Eur J Cancer 34(4):503–509CrossRefGoogle Scholar
  23. 23.
    Ovesen L, Allingstrup L, Hannibal J, Mortensen EL, Hansen OP (1993) Effect of dietary counseling on food intake, body weight, response rate, survival, and quality of life in cancer patients undergoing chemotherapy: a prospective, randomized study. J Clin Oncol 11:2043–2049CrossRefGoogle Scholar
  24. 24.
    Van Eys J (1982) Effect of nutritional status on response to therapy. Cancer Res 42(2 Suppl):747–753Google Scholar
  25. 25.
    Tubiana M, Attié E, Flamant R et al (1971) Prognostic factors in 454 cases of Hodgkin’s disease. Cancer Res 31:1801–1810Google Scholar
  26. 26.
    Swenerton KD, Legha SS, Smith T et al (1979) Prognostic factors in metastatic breast cancer treated with combination chemotherapy. Cancer Res 39(5):1552–1562Google Scholar
  27. 27.
    Prado CM, Lieffers JR, McCargar LJ et al (2008) Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol 9(7):629–635CrossRefGoogle Scholar
  28. 28.
    Martin L, Birdsell L, Macdonald N et al (2013) Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J Clin Oncol 31:1539–1547CrossRefGoogle Scholar
  29. 29.
    Tan BH, Brammer K, Randhawa N et al (2015) Sarcopenia is associated with toxicity in patients undergoing neo-adjuvant chemotherapy for oesophago-gastric cancer. Eur J Surg Oncol 41(3):333–338CrossRefGoogle Scholar
  30. 30.
    Anandavadivelan P, Brismar TB, Nilsson M et al (2016) Sarcopenic obesity: a probable risk factor for dose limiting toxicity during neo-adjuvant chemotherapy in oesophageal cancer patients. Clin Nutr 35(3):724–730CrossRefGoogle Scholar
  31. 31.
    Palmela C, Velho S, Agostinho L et al (2017) Body composition as a prognostic factor of neoadjuvant chemotherapy toxicity and outcome in patients with locally advanced gastric Cancer. J Gastric Cancer 17(1):74–87CrossRefGoogle Scholar
  32. 32.
    Lecleire S, Di Fiore F, Antonietti M et al (2006) Undernutrition is predictive of early mortality after palliative self-expanding metal stent insertion in patients with inoperable or recurrent esophageal cancer. Gastrointest Endosc 64(4):479–484CrossRefGoogle Scholar
  33. 33.
    Barao K, Abe Vicente Cavagnari M, Silva Fucuta P, Manoukian Forones N (2017) Association between nutrition status and survival in elderly patients with colorectal cancer. Nutr Clin Pract 32(5):658–663CrossRefGoogle Scholar
  34. 34.
    Miyamoto Y, Baba Y, Sakamoto Y et al (2015) Negative impact of skeletal muscle loss after systemic chemotherapy in patients with Unresectable colorectal Cancer. PLoS One 10(6):e0129742CrossRefGoogle Scholar
  35. 35.
    Fujiwara N, Nakagawa H, Kudo Y et al (2015) Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma. J Hepatol 63(1):131–140CrossRefGoogle Scholar
  36. 36.
    Iritani S, Imai K, Takai K et al (2015) Skeletal muscle depletion is an independent prognostic factor for hepatocellular carcinoma. J Gastroenterol 50(3):323–332CrossRefGoogle Scholar
  37. 37.
    Kamachi S, Mizuta T, Otsuka T et al (2016) Sarcopenia is a risk factor for the recurrence of hepatocellular carcinoma after curative treatment. Hepatol Res 46(2):201–208CrossRefGoogle Scholar
  38. 38.
    van Vledder MG, Levolger S, Ayez N et al (2012) Body composition and outcome in patients undergoing resection of colorectal liver metastases. Br J Surg 99(4):550–557CrossRefGoogle Scholar
  39. 39.
    Arends J, Bachmann P, Baracos V et al (2017) ESPEN guidelines on nutrition in cancer patients. Clin Nutr 36(1):11–48CrossRefGoogle Scholar
  40. 40.
    Baldwin C, Weekes CE (2012) Dietary counselling with or without oral nutritional supplements in the management of malnourished patients: a systematic review and meta-analysis of randomised controlled trials. J Hum Nutr Diet 25(5):411–426CrossRefGoogle Scholar
  41. 41.
    Baldwin C, Spiro A, Ahern R, Emery PW (2012) Oral nutritional interventions in malnourished patients with cancer: a systematic review and meta-analysis. J Natl Cancer Inst 104(5):371–385CrossRefGoogle Scholar
  42. 42.
    Persson CR, Johansson BB, Sjöden PO, Glimelius BL (2002) A randomized study of nutritional support in patients with colorectal and gastric cancer. Nutr Cancer 42(1):48–58CrossRefGoogle Scholar
  43. 43.
    Baldwin C, Spiro A, McGough C et al (2011) Simple nutritional intervention in patients with advanced cancers of the gastrointestinal tract, non-small cell lung cancers or mesothelioma and weight loss receiving chemotherapy: a randomised controlled trial. J Hum Nutr Diet 24(5):431–440CrossRefGoogle Scholar
  44. 44.
    Bourdel-Marchasson I, Blanc-Bisson C, Doussau A et al (2014) Nutritional advice in older patients at risk of malnutrition during treatment for chemotherapy: a two-year randomized controlled trial. PLoS One 9(9):e108687CrossRefGoogle Scholar
  45. 45.
    Kuroda H, Ushio A, Miyamoto Y et al (2010) Effects of branched-chain amino acid-enriched nutrient for patients with hepatocellular carcinoma following radiofrequency ablation: a one-year prospective trial. J Gastroenterol Hepatol 25(9):1550–1555CrossRefGoogle Scholar
  46. 46.
    Fearon KC, Von Meyenfeldt MF, Moses AG et al (2003) Effect of a protein and energy dense N-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial. Gut 52(10):1479–1486CrossRefGoogle Scholar
  47. 47.
    Moses AW, Slater C, Preston T et al (2004) Reduced total energy expenditure and physical activity in cachectic patients with pancreatic cancer can be modulated by an energy and protein dense oral supplement enriched with n-3 fatty acids. Br J Cancer 90(5):996–1002CrossRefGoogle Scholar
  48. 48.
    Bauer J, Capra S, Battistutta D, Cancer Cachexia study group et al (2005) Compliance with nutrition prescription improves outcomes in patients with unresectable pancreatic cancer. Clin Nutr 24(6):998–1004CrossRefGoogle Scholar
  49. 49.
    Shirai Y, Okugawa Y, Hishida A et al (2017) Fish oil-enriched nutrition combined with systemic chemotherapy for gastrointestinal cancer patients with cancer cachexia. Sci Rep 7(1):4826CrossRefGoogle Scholar
  50. 50.
    Lundholm K, Daneryd P, Bosaeus I et al (2004) Palliative nutritional intervention in addition to cyclooxygenase and erythropoietin treatment for patients with malignant disease: effects on survival, metabolism, and function. Cancer 100(9):1967–1977CrossRefGoogle Scholar
  51. 51.
    Lundholm K, Körner U, Gunnebo L et al (2007) Insulin treatment. Cancer cachexia: effects on survival, metabolism, and physical functioning. Clin Cancer Res 13(9):2699–2706CrossRefGoogle Scholar
  52. 52.
    Obling SR, Wilson VB, Pfeiffer P, Kjeldsen J (2017) Home parenteral nutrition increases fat-free mass in incurable gastrointestinal cancer patients. Results of a randomised clinical trial. Clin Nutr.  https://doi.org/10.1016/j.clnu.2017.12.011
  53. 53.
    Bozzetti F (2017) Forcing the vicious circle: sarcopenia increases toxicity, decreases response to chemotherapy and worsens with chemotherapy. Ann Oncol 28(9):2107–2118CrossRefGoogle Scholar
  54. 54.
    Solheim TS, Laird BJ (2012) Evidence base for multimodal therapy in cachexia. Curr Opin Support Palliat Care 6(4):424–431CrossRefGoogle Scholar
  55. 55.
    Solheim TS, Laird BJA, Balstad TR, Stene GB, Bye A, Johns N, Pettersen CH, Fallon M, Fayers P, Fearon K, Kaasa S (2017) A randomized phase II feasibility trial of a multimodal intervention for the management of cachexia in lung and pancreatic cancer. J Cachexia Sarcopenia Muscle 8(5):778–788CrossRefGoogle Scholar
  56. 56.
    Temel JS, Greer JA, Muzikansky A et al (2010) Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med 363(8):733–742CrossRefGoogle Scholar
  57. 57.
    Grosvenor M, Bulcavage L, Chlebowski RT (1989) Symptoms potentially influencing weight loss in a cancer population. Correlations with primary site, nutritional status, and chemotherapy administration. Cancer 63:330–334CrossRefGoogle Scholar
  58. 58.
    Cotogni P, De Carli L, Passera R et al (2017) Longitudinal study of quality of life in advanced cancer patients on home parenteral nutrition. Cancer Med 6(7):1799–1806CrossRefGoogle Scholar
  59. 59.
    Culine S, Chambrier C, Tadmouri A et al (2014) Home parenteral nutrition improves quality of life and nutritional status in patients with cancer: a French observational multicentre study. Support Care Cancer 22(7):1867–1874CrossRefGoogle Scholar
  60. 60.
    Vashi PG, Dahlk S, Popiel B et al (2014) A longitudinal study investigating quality of life and nutritional outcomes in advanced cancer patients receiving home parenteral nutrition. BMC Cancer 14:593.  https://doi.org/10.1186/1471-2407-14-593 CrossRefGoogle Scholar
  61. 61.
    Lim STK, Choa RG, Lan KH, Ong GB (1981) Total parenteral nutrition versus gastrostomy in the preoperative preparation of patients with carcinoma of the oesophagus. Br J Surg 68:69–72CrossRefGoogle Scholar
  62. 62.
    Pearlstone DB, Lee JI, Alexander RH, Chang TH, Brennan MF, Burt M (1995) Effect of enteral and parenteral nutrition on amino acid levels in cancer patients. JPEN J Parenter Enteral Nutr 19:204–208CrossRefGoogle Scholar
  63. 63.
    Burt ME, Stein TP, Brennan MF (1983) A controlled, randomized trial evaluating the effects of enteral and parenteral nutrition on protein metabolism in cancer-bearing man. J Surg Res 34:303–314CrossRefGoogle Scholar
  64. 64.
    Nixon DW, Lawson DH, Kutner M, Ansley J, Schwarz M, Heymsfield S, Chawla R, Cartwright TH, Rudman D (1981) Hyperalimentation of the cancer patient with protein-calorie undernutrition. Cancer Res 41:2038–2045Google Scholar
  65. 65.
    Dresler CM, Jeevanandam M, Brennan MF (1987) Metabolic efficacy of enteral feeding in malnourished cancer and noncancer patients. Metabolism 36:82–88CrossRefGoogle Scholar
  66. 66.
    Orrevall Y, Tishelman C, Permert J (2005) Home parenteral nutrition: a qualitative interview study of the experiences of advanced cancer patients and their families. Clin Nutr 24(6):961–970CrossRefGoogle Scholar
  67. 67.
    Orrevall Y, Tishelman C, Permert J, Lundström S (2013) A national observational study of the prevalence and use of enteral tube feeding, parenteral nutrition and intravenous glucose in cancer patients enrolled in specialized palliative care. Nutrients 5(1):267–282CrossRefGoogle Scholar
  68. 68.
    Scolapio JS, Picco MF, Tarrosa VB (2002) Enteral versus parenteral nutrition: the patient’s preference. JPEN J Parenter Enteral Nutr 26(4):248–250CrossRefGoogle Scholar
  69. 69.
    Hopkinson J, Corner J (2006) Helping patients with advanced cancer live with concerns about eating: a challenge for palliative care professionals. J Pain Symptom Manag 31(4):293–305CrossRefGoogle Scholar
  70. 70.
    Hopkinson JB, Wright DN, McDonald JW, Corner JL (2006) The prevalence of concerns about weight loss and change in eating habits in people with advanced cancer. J Pain Symptom Manag 32(4):322–331CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Faculty of MedicineUniversity of MilanMilanItaly

Personalised recommendations